"
Team:BIT-China/Safety
From 2014.igem.org
| Line 139: | Line 139: | ||
<div id="nav"> | <div id="nav"> | ||
<ul> | <ul> | ||
| - | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:BIT-China/Project"><img src="https://static.igem.org/mediawiki/2014/b/b3/BIT-CHINA_1.png |
" /></a></li> | " /></a></li> | ||
| - | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:BIT-China/Modeling"><img src="https://static.igem.org/mediawiki/2014/1/18/BIT-CHINA_2.png |
" /></a></li> | " /></a></li> | ||
| - | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:BIT-China/Practice"><img src="https://static.igem.org/mediawiki/2014/1/15/BIT-CHINA_3.png |
" /></a></li> | " /></a></li> | ||
| - | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:BIT-China/Judging"><img src="https://static.igem.org/mediawiki/2014/3/3e/BIT-CHINA_4.png |
" /></a></li> | " /></a></li> | ||
</ul> | </ul> | ||
| Line 151: | Line 151: | ||
<div id="nav1"> | <div id="nav1"> | ||
<ul> | <ul> | ||
| - | <li style="top:50px"><a href=" | + | <li style="top:50px"><a href="https://2014.igem.org/Team:BIT-China/Safety"><img src="https://static.igem.org/mediawiki/2014/b/b7/BIT-CHINA_5.png |
" /></a></li> | " /></a></li> | ||
| - | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:BIT-China/Team"><img src="https://static.igem.org/mediawiki/2014/c/ca/BIT-CHINA_6.png |
" /></a></li> | " /></a></li> | ||
| - | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:BIT-China/Notebook"><img src="https://static.igem.org/mediawiki/2014/7/72/BIT-CHINA_7.png |
" /></a></li> | " /></a></li> | ||
| - | <li><a href=" | + | <li><a href="https://2014.igem.org/Team:BIT-China/Sponsor"><img src="https://static.igem.org/mediawiki/2014/8/89/BIT-CHINA_8.png" /></a></li> |
</ul> | </ul> | ||
</div> | </div> | ||
Revision as of 22:11, 16 October 2014
As is described in background, one of our project’s main application is preventing the disclosure of pathogen which is operating in lab. Thus, the focused on normal safety problems.
Question
(1) Have your team members received any safety training yet?
Answer: Of course. Although some of our team members are freshmen and sophomores, all of us are well trained before we start to make some experiments. What’s more, one of the main purpose of our project is to contain pathogens in the lab, we all have accepted strict safety training.
(2) Please briefly describe the topics that you learned about (or will learn about) in your safety training.
Answer:
1.The operating rules in the lab
2.The knowledge of biochemical safety
3.The way to protect our interests.
(3) What new risks might arise from your project's growth?
Answer: We developed a new method to depressed the disclosure of microorganisms.
(4) Risks to the environment , members and society:
Answer: Our target is to minimize the risk of bacteria operating in the lab, protect the environment and human beings.
(5) Does your project currently include any design features to reduce risks? Or, if you did all the future work to make your project grow into a popular product, would you plan to design any new features to minimize risks? (For example: auxotrophic chassis, physical containment, etc.) Such features are not required for an iGEM project, but many teams choose to explore them.
Answer:Our project’s main target is to minimize risks. As the description said, what we’ll do is to get rid of the risk of pathogens in the lab. Which means we developed a new way to protect human beings.
未完待续
Q:If cell division inhibition system comes from engineering bacteria, will it be easy for the bacteria to evolve a method to fight against it? If it is exogenous, will it be harm to the production progress?
A: We plan to use system from bacteria themselves, there is no need to worry about evolution. In fermentation progress bacteria will not be used more than once, there will always be the origin strain in the fermentation tank, the rest will be disposed.
